| Sign In to gain access to subscriptions and/or personal tools. |
Severe bone marrow failure associated with the use of alternating steroid with chlorambucil in lupus membranous nephropathy in ChineseDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, People's Republic of China; Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, N.T., Hong Kong, People's Republic of Chinaawang{at}cuhk.edu.hk
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, People's Republic of China
Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, People's Republic of China
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, People's Republic of China Severe pancytopenia associated with the use of alternating steroid with chlorambucil regimen was described in six patients with nephrotic syndrome secondary to lupus membranous nephropathy (WHO class V). We believe this is the first report describing the life-threatening degree of marrow toxicity associated with this regimen of alternating steroid with chlorambucil in a Chinese population. Our data suggests that the susceptibility to marrow toxicity with the use of chlorambucil may only be applicable to Chinese patients with underlying systemic lupus erythematosus as a similar degree of toxicity has neither been reported in lupus patients of other ethnic groups nor in non-lupus patients of Chinese origin.
Key Words: lupus membranous nephropathy chlorambucil pancytopenia
Lupus, Vol. 10, No. 4,
295-298 (2001) This article has been cited by other articles:
|
|||||||||||||||
